Ranee Mehra

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Monoclonal Antibody

Acute Lymphoblastic Leukemia

Small Cell Lung Cancer

Top Venues

OncoTargets and therapy

Patient preference and adherence

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Candice Yong, M Janelle Cambron-Mellott, Brian Seal, Oliver Will, Martine C Maculaitis, Kelly Clapp, Emily Mulvihill, Ion Cotarla, Ranee Mehra
Patient and Caregiver Preferences for First-Line Treatments of Metastatic Non-Small Cell Lung Cancer: A Discrete Choice Experiment. Patient preference and adherence 16 (2022)
Matthew J Ferris, Yael Flamand, Gregory S Weinstein, Shuli Li, Harry Quon, Ranee Mehra, Joaquin J Garcia, Christine H Chung, Maura L Gillison, Umamaheswar Duvvuri, Bert W O'Malley, Enver Ozer, Giovana R Thomas, Wayne M Koch, Neil D Gross, Richard B Bell, Nabil F Saba, Miriam N Lango, Eduardo Méndez, Barbara A Burtness
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Michael G McCusker, Dennis Orkoulas-Razis, Ranee Mehra
Potential of Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer: Evidence to Date. OncoTargets and therapy 13 (2020)
Jared Weiss, Siddharth Sheth, Allision M Deal, Juneko E Grilley Olson, Samip Patel, Trevor G Hackman, Jeffrey M Blumberg, Thomas J Galloway, Shetal Patel, Adam M Zanation, Colette J Shen, David Neil Hayes, Christopher Hilliard, Ranee Mehra, Karen P McKinnon, Hsing-Hui Wang, Mark Christian Weissler, Jessica R Bauman, Bhishamjit S Chera, Benjamin G Vincent
Concurrent Definitive Immunoradiotherapy for Patients with Stage III-IV Head and Neck Cancer and Cisplatin Contraindication. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (16) (2020)